Effectiveness of Eletriptan in Acute Migraine: Primary Care for Excedrin Nonresponders

Abstract

Previous studies have established the efficacy of eletriptan as a first-line treatment for migraine. The results of this open-label trial demonstrate that the 40-mg dose of eletriptan had a high degree of efficacy and tolerability among patients who were poor responders to Excedrin.